FDA 483 - Corey G. Anderson, M.D. - September 19, 2025

Corey G. Anderson, M.D. in Tempe, AZ, was inspected and cited for significant deficiencies in clinical trial conduct. The inspection revealed failures in reporting both serious and non-serious adverse events to the sponsor, conducting the investigation according to the protocol, and maintaining adequate case histories for biological samples. These issues indicate a lack of adherence to study protocols and proper record-keeping practices.